Gabriella Miller Kids First Research Act 2.0

Bill: 116-hr-6556
Sponsor: full_name: Rep. Wexton, Jennifer [D-VA-10]
Introduced: 2020-04-17
Policy area: Health
Subjects: Banking and financial institutions regulation

Child health

Civil actions and liability

Government trust funds

Health programs administration and funding

Medical research

Research administration and funding

Securities and Exchange Commission (SEC)
Latest action: action_date: 2020-04-17
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Summaries:
action_date: 2020-04-17
action_desc: Introduced in House
text: <p><b>Gabriella Miller Kids First Research Act 2.0</b></p> <p>This bill directs certain penalties assessed by the Securities Exchange Commission against pharmaceutical companies for specified violations to the 10-Year Pediatric&nbsp;Research Initiative Fund,&nbsp;an existing fund that supports&nbsp;pediatric disease research. In making allocations from that fund, the National Institutes of Health shall prioritize pediatric research that does not duplicate existing research activities. </p>

tv_txt: I 116th CONGRESS 2d Session H. R. 6556 IN THE HOUSE OF REPRESENTATIVES April 17, 2020 Ms. Wexton (for herself, Mr. Cole , Mr. Welch , and Mr. Bilirakis ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Financial Services , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To require certain civil penalties to be transferred to a fund through which amounts are made available for the Gabriella Miller Kids First Pediatric Research Program at the National Institutes of Health, and for other purposes.

1. Short title This Act may be cited as the Gabriella Miller Kids First Research Act 2.0 . 2. Transfer of funds to the 10-Year Pediatric Research Initiative Section 30A of the Securities Exchange Act of 1934 ( 15 U.S.C. 78dd–1 ) is amended by adding at the end the following: (h) Transfer of amounts (1) In general With respect to civil monetary sanctions, including penalties, disgorgement, and interest, recovered under this section, section 13(b)(2), or section 32(c) from persons registered under section 510(b)(1) or section 510(i)(1)(A)(i) of the Federal Food, Drug, and Cosmetic Act, the Secretary of the Treasury shall transfer to the 10-Year Pediatric Research Initiative Fund described in section 9008(i)(2) of the Internal Revenue Code of 1986 (the Fund ), an amount equal to the sum of all such sanctions. (2) Exception for funds to be paid to harmed investors Paragraph (1) shall not apply to any monetary sanction collected by the Commission in any judicial or administrative action brought by the Commission under the securities laws that is added to a disgorgement fund or other fund under section 308 of the Sarbanes-Oxley Act of 2002 ( 15 U.S.C. 7246 ) or otherwise distributed to victims of a violation of the securities laws, or the rules and regulations thereunder. (3) Application Amounts transferred to the Fund under this subsection shall— (A) be transferred in the manner described under section 9601 of the Internal Revenue Code of 1986; and (B) be available as described in section 9008(i)(2) of such Code. . 3. Funding for the 10-Year Pediatric Research Initiative Section 402A(a)(2) of the Public Health Service Act ( 42 U.S.C. 282a(a)(2) ) is amended by inserting before the period the following: , and amounts transferred into the 10-Year Pediatric Research Initiative Fund under section 30A(h) of the Securities Exchange Act of 1934 . 4. Coordination of NIH funding for pediatric research (a) Sense of Congress It is the sense of the Congress that the Director of the National Institutes of Health should oversee and coordinate research that is conducted or supported by the National Institutes of Health for research on pediatric cancer and other pediatric diseases and conditions, including through the 10-Year Pediatric Research Initiative Fund. (b) Avoiding duplication Section 402(b)(7)(B)(ii) of the Public Health Service Act ( 42 U.S.C. 282(b)(7)(B)(ii) ) is amended by inserting and shall prioritize such pediatric research that does not duplicate existing research activities of the National Institutes of Health before ; and .